CN Patent
CN101678112B — 用于递送治疗剂的方法和组合物
Assigned to HASKOLI ISLANDS · Expires 2016-08-31 · 10y expired
What this patent protects
本申请提供一种液体药物组合物,包含治疗剂和烷氧基‑聚乙二醇,例如甲氧基‑聚乙二醇,用于将治疗剂施用于哺乳动物。该组合物可以应用于膜,例如在鼻内施用期间用于鼻膜。本发明也提供将该组合物施用于哺乳动物的方法。
USPTO Abstract
本申请提供一种液体药物组合物,包含治疗剂和烷氧基‑聚乙二醇,例如甲氧基‑聚乙二醇,用于将治疗剂施用于哺乳动物。该组合物可以应用于膜,例如在鼻内施用期间用于鼻膜。本发明也提供将该组合物施用于哺乳动物的方法。
Drugs covered by this patent
- naloxone-hydrochloride (Naloxone Hydrochloride) · Pfizer Inc.
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.